openPR Logo
Press release

Testosterone Replacement Therapy Market - Promising Technology for Improving Top Industry: fizer, Inc., Acerus Pharmaceuticals Corporation, AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc

05-15-2019 05:35 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Testosterone Replacement Therapy

Testosterone Replacement Therapy

Hypogonadism in men is primarily characterized by reduced concentration of serum testosterone, causing decreased libido, erectile dysfunction, loss of body and facial hair, decreased bone density, weakness, decreased lean body mass, increased body fat, fatigue and anemia. Hypogonadism in adult men is often overlooked; even in the presence of associated symptoms, because the hypogonadism men often ignore the symptoms or they attribute them with alternate cause such as ageing.

Request Sample Copy of Research @ www.coherentmarketinsights.com/insight/request-sample/2024

Increasing prevalence of hypogonadism in adult men worldwide is expected to drive growth of the testosterone replacement therapy market. According to the European Association of Urology: 2016 report, in middle-aged men, the incidence of hypogonadism varies from 2.1% to 12.8%. The incidence of low testosterone and symptoms of hypogonadism in men aged 40-79 varies form 2.1% to 5.7%, in Europe. Hypogonadism is more prevalent in older men, in men with obesity, those with co-morbidities, and in men with a poor health status. Furthermore, according to the Therapeutics Advances of Urology Journal: 2016, testosterone has become one of the most widely prescribed medications in the U.S. in 2011.

Many experts says people with type II diabetes mellitus tend to associated with low testosterone level in the blood. Visceral obesity is important cause of insulin resistance, and important feature in type II diabetes. An increased deposition of abdominal adipose tissue in the hypogonadal patients, leads to decrease testosterone concentrations. According to the Indian Journal of Endocrinology and Metabolism, 2017; a study conducted on 900 men with type II diabetes mellitus (T2DM) to evaluate the testosterone deficiency reported that prevalence of hypogonadism in T2DM patients was found to be 20.7%. Moreover, the percentage prevalence of hypogonadism in patients with T2DM was moderate with highest number of patients belonging to age group 50–59 year.

Request for Customization of Research Report: www.coherentmarketinsights.com/insight/request-customizat...

For instance, according to International Diabetes Federation (IDF) Diabetes Atlas: 2017, number of people with diabetes aged between 20 to 79 years in South East Asia region and Western Pacific region in 2017, was 82 million and 159 million, respectively.

Some of the key players operating in the testosterone replacement therapy market include AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Key players in these market are engaged in product regulatory approval and new product launch strategies to maintain competitive position in the market. For instance, in March 2017, U.S. FDA approved Abbreviated New Drug Application (ANDA) of Perrigo Company plc, for making the generic version of Eli Lilly and Company's Axiron topical solution, 30 mg/1.5 mL (testosterone topical solution, 30 mg/1.5 mL).

Request A consult-us @ https://www.coherentmarketinsights.com/insight/consult-us/2024

Endo International Inc. is being an innovative player in the testosterone replacement therapy market, which engaged in launching novel and innovative product in these market. For instance, in March 2015, Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, launched NATESTO (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Testosterone Replacement Therapy Market - Promising Technology for Improving Top Industry: fizer, Inc., Acerus Pharmaceuticals Corporation, AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc here

News-ID: 1739289 • Views: 294

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Endo

Flame Resistant Clothing Market Outlook to 2023 – Body Products, Changzhou Hea …
Sept 2018, New York USA (News)- Researchreportsinc.com adds "Global Flame Resistant Clothing Market: Size, Trends & Forecasts (2018-2023)" report to its research store. This research provides market analysis of size, share, trends, value, volume, country coverage, market dynamics, and competitive landscape. Request for FREE Sample of Global Flame Resistant Clothing Market 2018 Research Report @ https://www.researchreportsinc.com/sample-request?id=196756 The global market size of Flame Resistant Clothing Market is $XX million in 2017 with
Worldwide Transdermal Drug Delivery Systems Industry 2018 | Top Players- Endo In …
The Global TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics,
Global Perphenazines Market 2018 - Teva, Sandoz, Endo, Mylan
Apex Market Reports, recently published a detailed market research study focused on the “Perphenazines Market” across the global, regional and country level. The report provides 360° analysis of “Perphenazines Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Perphenazines on the basis of
Global Polypectomy Snares Market 2018 - Blue Endo, Carmonja, EMED, Endo-Flex
The statistical surveying information incorporated into the Polypectomy Snares report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Polypectomy Snares based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Polypectomy Snares advertise covering key factors, for example, drivers and
Polypectomy Snares Market - Blue Endo (USA), Changzhou Health Microport Medical …
Global Polypectomy Snares Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Polypectomy Snares Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players: Blue Endo (USA) Changzhou Health Microport Medical Devices (China) EMED (Poland) Endo-Flex (Germany) Endo-Therapeutics (USA) EndoChoice (USA) ENDOMED (Germany) Healthcare Medical Changzhou (China) Jiangsu Kangjin Medical Instruments (China) Medi-Globe (Germany) Mednova Medical Technology (China) Ovesco Endoscopy (Germany) Pauldrach Medical (Germany) Sejong
Lidocaine Patches Market 2017 - Acorda Therapeutics, Endo International, GlaxoSm …
Apex Research, recently published a detailed market research study focused on the "Lidocaine Patches Market" across the global, regional and country level. The report provides 360° analysis of "Lidocaine Patches Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lidocaine Patches industry, and estimates the future trend of Lidocaine Patches market on